证券记录 · 已归档季度
DAWN
Day One Biopharmaceuticals, Inc. · Healthcare · Biotechnology
13被追踪持有人
-1Δ持有人
9.77M持有股份
$136.05M报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -7.1% ·
股份流向 +13.3% ·
净新建仓位 -7.7%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 86 | +1 | 49.82M | $1.05B | +13 | −13 |
| Q4 2025 | 86 | +2 | 51.33M | $478.37M | +3 | — |
| Q3 2025 | 15 | -1 | 35.84M | $252.66M | — | −2 |
| Q2 2025 | 14 | -1 | 36.93M | $240.03M | +1 | −2 |
| Q1 2025 | 12 | -2 | 10.53M | $83.51M | — | −2 |
| Q4 2024 | 14 | 0 | 10.71M | $135.72M | +1 | −1 |
| Q3 2024 | 13 | -1 | 9.77M | $136.05M | +1 | −2 |
| Q2 2024 | 14 | — | 8.62M | $118.84M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 2.56M | 0.0% | $35.64M | 0.1% | Held | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.54M | +8.2% | $35.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 2.54M | +8.2% | $35.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.43M | +10.5% | $19.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.43M | +10.5% | $19.96M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 900.00K | 新增 | $12.54M | 0.0% | New | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 721.58K | +142.1% | $10.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 721.58K | +142.1% | $10.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 721.58K | +142.1% | $10.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 721.58K | +142.1% | $10.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 484.26K | +31.0% | $6.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 484.26K | +31.0% | $6.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 407.50K | +36.2% | $5.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Norges Bank ✦ (被动) | 169.00K | 0.0% | $2.35M | 0.0% | Held | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 143.13K | -36.2% | $1.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 143.13K | -36.2% | $1.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 130.31K | +15.3% | $1.82M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 130.31K | +15.3% | $1.82M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Millennium Management ✦ | 106.49K | -36.5% | $1.48M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 94.84K | +31.5% | $1.32M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 73.30K | 0.0% | $1.02M | 0.0% | Held | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $12.54M | 0.0% |
已清仓
| Point72 Asset Management | $6.48M | 曾为 0.0% |
| Marshall Wace | $2.22M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 206 持有人, 83.68M 股份, $1.67B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据